⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29042552 | 0.78 | — | — | |
| SCHEMBL17275122 | 0.77 | — | — | |
| SCHEMBL28715426 | 0.69 | — | — | |
| SCHEMBL6140728 | 0.67 | — | — | |
| SCHEMBL15302823 | 0.67 | — | — | |
| SCHEMBL11552215 | 0.66 | — | — | |
| SCHEMBL322752 | 0.66 | — | — | |
| SCHEMBL28589597 | 0.63 | — | — | |
| SCHEMBL28897639 | 0.59 | — | — | |
| SCHEMBL11807596 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250049841-A1 | NITRIC OXIDE-RELEASING NASAL COMPOSITIONS AND METHODS OF USE THEREOF | LIGAND PHARMACEUTICALS INCORPORATED | 2025-02-13 | — | — | US | claimed |
| EP-4447946-A1 | NITRIC OXIDE-RELEASING NASAL COMPOSITIONS AND METHODS OF USE THEREOF | LNHC, INC. (US) | 2024-10-23 | — | — | EP | claimed |
| WO-2023114971-A1 | NITRIC OXIDE-RELEASING NASAL COMPOSITIONS AND METHODS OF USE THEREOF | NOVAN, INC. (US) | 2023-06-22 | — | — | WO | claimed |
| US-20220168336-A1 | NITRIC OXIDE RELEASING SUPPOSITORIES AND METHODS OF USE THEREOF | LNHC, INC. | 2022-06-02 | — | — | US | claimed |
| EP-3758679-A1 | NITRIC OXIDE RELEASING SUPPOSITORIES AND METHODS OF USE THEREOF | Novan, Inc. (US) | 2021-01-06 | — | — | EP | claimed |
| CN-112165935-A | Nitric oxide-releasing suppository and method of use | 诺万公司 | 2021-01-01 | — | — | CN | claimed |
| US-20200397815-A1 | NITRIC OXIDE RELEASING SUPPOSITORIES AND METHODS OF USE THEREOF | LIGAND PHARMACEUTICALS INCORPORATED | 2020-12-24 | — | — | US | claimed |
| EP-3758679-B1 | NITRIC OXIDE RELEASING SUPPOSITORIES AND METHODS OF USE THEREOF | LIGAND PHARM INC (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20250049841-A1 | NITRIC OXIDE-RELEASING NASAL COMPOSITIONS AND METHODS OF USE THEREOF | LIGAND PHARMACEUTICALS INCORPORATED | 2025-02-13 | — | — | US | disclosed |
| EP-4447946-A1 | NITRIC OXIDE-RELEASING NASAL COMPOSITIONS AND METHODS OF USE THEREOF | LNHC, INC. (US) | 2024-10-23 | — | — | EP | disclosed |
| WO-2023114971-A1 | NITRIC OXIDE-RELEASING NASAL COMPOSITIONS AND METHODS OF USE THEREOF | NOVAN, INC. (US) | 2023-06-22 | — | — | WO | disclosed |
| US-20230144853-A1 | TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME | LNHC, INC. | 2023-05-11 | — | — | US | disclosed |
| US-11534382-B2 | Topical compositions and methods of using the same | NOVAN, INC. (US) | 2022-12-27 | — | — | US | disclosed |
| US-20220168336-A1 | NITRIC OXIDE RELEASING SUPPOSITORIES AND METHODS OF USE THEREOF | LNHC, INC. | 2022-06-02 | — | — | US | disclosed |
| US-11285171-B2 | Nitric oxide releasing suppositories and methods of use thereof | NOVAN, INC. (US) | 2022-03-29 | — | — | US | disclosed |
| US-20210137810-A1 | TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME | LIGAND PHARMACEUTICALS INCORPORATED | 2021-05-13 | — | — | US | disclosed |
| EP-3758679-A1 | NITRIC OXIDE RELEASING SUPPOSITORIES AND METHODS OF USE THEREOF | Novan, Inc. (US) | 2021-01-06 | — | — | EP | disclosed |
| CN-112165935-A | Nitric oxide-releasing suppository and method of use | 诺万公司 | 2021-01-01 | — | — | CN | disclosed |
| US-20200397815-A1 | NITRIC OXIDE RELEASING SUPPOSITORIES AND METHODS OF USE THEREOF | LIGAND PHARMACEUTICALS INCORPORATED | 2020-12-24 | — | — | US | disclosed |
| WO-2018236803-A1 | TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME | NOVAN, INC. (US) | 2018-12-27 | — | — | WO | disclosed |